Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants

Antimicrob Agents Chemother. 2006 Aug;50(8):2860-2. doi: 10.1128/AAC.00303-06.

Abstract

The distribution and resistance levels of 189 in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants of Beijing and other genotypes were determined. Apart from a higher amount of codon 522 point mutations and large deletions, a spread of mutations similar to that reported for clinical isolates was seen. Most mutations were correlated with high-level resistance; a lower level, or a MIC of <16 mg/liter, was associated with codon 522 mutations. Multiple mutations were detected in two Beijing mutants.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Antibiotics, Antitubercular / pharmacology*
  • Bacterial Proteins / genetics*
  • Base Sequence
  • DNA-Directed RNA Polymerases
  • Drug Resistance, Microbial / genetics
  • Humans
  • In Vitro Techniques
  • Microbial Sensitivity Tests
  • Mutation*
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / isolation & purification
  • Point Mutation
  • Rifampin / pharmacology*
  • Sequence Deletion

Substances

  • Antibiotics, Antitubercular
  • Bacterial Proteins
  • rpoB protein, Mycobacterium tuberculosis
  • DNA-Directed RNA Polymerases
  • Rifampin